tiprankstipranks
Sensus Healthcare, Inc. (SRTS)
NASDAQ:SRTS
US Market
Want to see SRTS full AI Analyst Report?

Sensus Healthcare (SRTS) Earnings Dates, Call Summary & Reports

425 Followers

Earnings Data

Report Date
Jul 30, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.12
Last Year’s EPS
-0.06
Same Quarter Last Year
Based on 3 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 07, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call presents a mixed but strategically constructive picture: strong operational catalysts (dedicated CPT codes, ~300% reimbursement increase, SensusLink launch, shipment activity, 8% treatment volume growth, solid cash position) that support a transition toward recurring revenue and broader adoption, contrasted with a sharp year-over-year revenue decline (~59%), significant margin compression (gross margin down to 29.2% from 52.2%), a larger adjusted EBITDA loss, and near-term revenue recognition/mix headwinds. Management is optimistic about sequential improvement (Q2 > Q1 and H2 > H1) and achieving full‑year profitability, but near-term financial performance remains challenged during the transition.
Company Guidance
Management guided that Q2 revenue should be higher than Q1 ($3.4M) and the second half of 2026 should exceed the first half as the company builds toward full‑year profitability with sequential quarter‑over‑quarter improvement; Q1 results included revenue $3.4M (vs. $8.3M PY; excluding the largest PY customer revenue was $2.7M), gross profit $1.0M and gross margin 29.2% (vs. 52.2% PY), cost of sales $2.4M, adjusted EBITDA -$4.2M (vs. -$2.5M PY), net loss $2.6M or $0.16 per share, cash $18.3M, no debt and inventory $16.5M, and operational highlights of 14 systems shipped (10 direct, 4 FDA/rental), ~965 total installed systems, ~70% of Q1 shipments purchased vs. FDA, treatment volumes +8% YoY, 18 active FDA sites and 9 pending, rollout of SensusLink (live) to drive recurring revenue (historically ~10% of revenue) from FDA, service and software, a ~300% increase in the per‑fraction delivery code, an average radiation‑physics reimbursement of ~$93.85/week (~$930 over ten weeks), and the note that the largest 2025 customer is not included in 2026 guidance (would be upside if they return).
Dedicated CPT Codes Implemented
New dedicated CPT codes for superficial radiotherapy effective Jan 1, 2026; management reports clearer reimbursement environment and increased market confidence, enabling broader adoption and simpler coding for dermatology SRT.
Substantial Reimbursement Increase
Per-fraction delivery code increased by approximately 300%, materially improving physician economics and contributing to stronger inquiry levels and pipeline development.
Product Shipments and Installations
Shipped 14 SRT systems in Q1 (10 direct sales, 4 Fair Deal / rental placements); total installed base approximately 965 systems globally; Q1 shipments matched Q4 levels and management expects quarter-over-quarter improvement.
Recurring and Utilization Momentum
Treatment volumes increased 8% year-over-year; 18 active FDA sites and 9 pending activations; management emphasizes growth of utilization-based revenue through FDA placements, rentals, service and software.
SensusLink Launch
SensusLink software is live and deployed in several accounts, intended to drive recurring software/service revenue, enable billing of radiation physics consult code, and share weekly reimbursement (example: ~$93.85/week per patient protocol).
Shift Toward Purchases and Improved Breakeven
Approximately 70% of systems shipped in Q1 were purchases versus FDA; average breakeven for customers is now ~2 patients per month, encouraging earlier ownership decisions.
Strong Balance Sheet
Cash of $18.3 million and no debt at quarter end, providing liquidity to execute the transition strategy and support commercial expansion.
Reduced Operating Expenses
Quarterly expense reductions year-over-year: G&A down to $2.0M from $2.2M, Selling & Marketing down to $1.7M from $2.2M, and R&D down to $1.6M from $2.6M, reflecting disciplined cost management.
Pipeline and Commercial Engagement
Strong lead generation from major dermatology conferences (including AAD) and increasing engagement from independent dermatology practices, group networks, hospital systems and private equity-backed platforms; launched Sensus Healthcare Financial Services to improve conversion with flexible financing.

Sensus Healthcare (SRTS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SRTS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 30, 2026
2026 (Q2)
-0.12 / -
-0.06
May 07, 2026
2026 (Q1)
-0.13 / -0.16
-0.160.00% (0.00)
Feb 12, 2026
2025 (Q4)
-0.07 / -0.19
0.09-311.11% (-0.28)
Nov 06, 2025
2025 (Q3)
-0.10 / -0.06
0.07-185.71% (-0.13)
Aug 07, 2025
2025 (Q2)
0.03 / -0.06
0.1-160.00% (-0.16)
May 15, 2025
2025 (Q1)
0.03 / -0.16
0.14-214.29% (-0.30)
Feb 05, 2025
2024 (Q4)
0.12 / 0.09
0.26-65.38% (-0.17)
Nov 14, 2024
2024 (Q3)
-0.01 / 0.07
-0.09177.78% (+0.16)
Aug 08, 2024
2024 (Q2)
0.02 / 0.10
-0.02600.00% (+0.12)
May 09, 2024
2024 (Q1)
-0.04 / 0.14
-0.12216.67% (+0.26)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SRTS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 07, 2026
$4.11$3.08-25.06%
Feb 12, 2026
$4.65$3.86-16.99%
Nov 06, 2025
$3.52$4.20+19.32%
Aug 07, 2025
$5.35$3.46-35.23%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sensus Healthcare, Inc. (SRTS) report earnings?
Sensus Healthcare, Inc. (SRTS) is schdueled to report earning on Jul 30, 2026, After Close (Confirmed).
    What is Sensus Healthcare, Inc. (SRTS) earnings time?
    Sensus Healthcare, Inc. (SRTS) earnings time is at Jul 30, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SRTS EPS forecast?
          SRTS EPS forecast for the fiscal quarter 2026 (Q2) is -0.12.